FDA Investigator Michele L Glendenning

Michele L Glendenning has conducted inspections on 93 sites in 6 countries as of 29 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
93
Last Inspection Date:
29 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, India, China, Brazil, Korea (Republic of), Australia
FDA Investigators that have inspected at least one site in common with Michele L Glendenning:
Adam J Taylor, Aditi S Thakur, Alan A Rivera, Alan M Barker, Alicia M Mozzachio, Amanda S Zorn, Amy Devlin, PhD, Ana E Morales, Ana Paulap Sandee, Anastasia M Shields, Anders W Evenson, Andrew A Leboeuf, Andrew J Barrowcliff, Anita Narula, PhD, Anthony F Lorenzo, Arsen Karapetyan, Ashley L Reiber, Audrey Dela Cruz, Ava M Bowman, Benjamin J Smith, Bo Chi, PhD, Brentley S Collins, Brett R Havranek, Brian A Roelofs, Brian D Nicholson, Brian P Emanuel, Brittani N Franklin, Bruce H Mccullough, Bryan L Mcguckin, Burnell M Henry, Carl A Huffman, III, Carol A Gripp, Carrie Ann Plucinski, CDR Ileana Barreto Pettit, CDR Sean T Creighton, Chad E Schmear, Chad J Whitwell, Chad W Rice, Charles L Zhou, Charles M Spyr, Cheng H Yen, Christina A Miller, Christopher D Leach, Connie L Richard, Constance L Richard, Constantin Y Philopoulos, Cynthia A Harris, MD, RN, Cynthia Jim, CSO, Dana M Lewis, Daniel B Arrecis, Daniel J Brown, Dariusz Galezowski, Darrell E Luedtke, David A Paterson, David J Gasparovich, David M Beltran, David Perkins, Debra I Love, Debra Lboyd Seale, Denarvis C Mendenhall, Denise L Burosh, Denise M Digiulio, Dennis Cantellops Paite, Dilip Devineni, PhD, Donna A Katz, Dr. Gang Wang, PhD, Dr. Robert C Horan, MD, E Sextonl, Eboni S Funderburk, Ebony D Sanon, Eileen A Liu, Elizabeth L Philpy, Emest F Bizjak, Emily J Orban, Enrico Joset Mangahis, Eric M Mueller, PharmD, Eric S Pittman, Erin A Wall, Frank Wackes, Freed A Sharif, Gabriel Bermudez Picart, Geoffrey K Kilili, Goran Periz, PhD, Gordon T Wales, Greg Brinsley, Gregory R Brinsley, Gregory R Dill, Gregory W Smith, Hamet M Toure, PharmD MPH, Helen B Ricalde, Howard Sklamberg, Ian L Mcwilliams, Ifueko Osemwota, Insook Son, Jacob G Lutz, Jacob W Reynolds, Jacqueline Mdiaz Albertini, James E Roberts, James W Plucinski, Jamie R Thompson, Janae D Price, Janis R Armedoriz, Jason F Chancey, Jeanne J Chiu, Jeanne J Thai, Jeanne M Morris, Jeffrey A Sommers, Jeffrey D Meng, Jeffry A Bernhardt, Jennifer A D'angelo, Jennifer C Adams, Jennifer C Johnson, Jennifer L Schmidt, Jennifer M Gogley, Jesse A Vazquez, Jesse P Romenesko, Jessica L Barr, Jill J Tillman, Jocelyn C Turner, Joel D Hustedt, Jogy George, John M Seale, John Misock, Jonathan G Swoboda, Jose A Lopez, Jose Acruz Gonzalez, José E Meléndez, Jose M Cayuela, Joseph A Morkunas, Joseph A Piechocki, Joseph D Cooper, Joshua M Adams, Joslyn K Brunelle, PhD, Juanita P Versace, Justin A Boyd, Kalavati Suvarna, PhD, Karen Emasley Joseph, Katherine Szestypalow, Kathleen S Tormey, Kathryn M Mogen, Kevin P Regan, Kristen D Evans, Kshitij A Patkar, Kyran R Gibson, Lana K Waselewski, Larry F Hallberg, Larry K Austin, Latoya A Griffith, Laurel A Beer, Lauren A Crivellone, Lauren N Howard, Laurie A Haxel, Laurie Graham, Laurimer Kuilan Torres, LCDR Mark A Jimenez, RN, Lee Terry Moore, Leonard H Lavi, Lequita M Mayhew, Libia M Lugo, Linda F Murphy, Lisa C Lewis, Lisa Hornback, Lorelei S Jarrell, Maksim A Levenchuk, Marc R Dickens, Marcia A Worley, Margaret L Bolte, Margaret Torres Vazquez, Maria Diaz, Marian E Ramirez, Marie B Buen Bigornia, Marisa E Stock, Mark E Frank, Mark G Peterson, Mark I Kaspar, Martin R Vowell, Massod Rahimi, PhD, Matthew B Casale, Meisha R Sampson, Meisha Waters, Michael A Taylor, Michael D Robinson, Michael L Chasey, Michael Shanks, MS, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Milva E Melendez Perales, Monica E Murie, Muna Algharibeh, Nibin Varghese, MS, Nicholas A Violand, Nicholas F Lyons, Nicholas J Presto, Nicholas L Paulin, Nicholas P Diorio, Nicholas Z Lu, Nicole C Shokatz, Nicole J Clausen, Norman K Starks, Norman Wong, Omotunde O Osunsanmi, Pablo Alcantara, Paola S Barnett, Patricia A Mcilroy, Patrick C Klotzbuecher, Patrick E Gainer, Patsy J Domingo, Paul L Bellamy, Paul M Chefor, Paula A Trost, Paula P Demichael, Peng Zhou, Phung Thien Nguyen, Prabhu P Raju, Rachel T Evans, Ralph A Erickson, Ralph H Vocque, Ramon A Hernandez, Randy L Self, Rebecca E Dombrowski, Rebecca K Olin, Rebecca Rodriguez, Richard L Friedman, Richard Ledwidge (nmi), PhD, Richard M Willey, Rita K Kabaso, Robert D Tollefsen, Robert J Ham, Robert M Barbosa, Roberta W Cunningham, Rose Ashley, Rose Ljean Mary, Rose Xu, Rosemary Wood Sexton, Roshni J Patel, Ross J Grigsby, Ruben C Ayala, PharmD, Russell K Riley, Ryan S Martin, Sam H Haidar, PhD, Samina S Khan, Sandra A Boyd, Sandra A Hughes, Sarah B Tanksley, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sarah Nwandiuko, Scott B Laufenberg, Scott T Ballard, Shafiq S Ahadi, Shalonda C Clifford, Shana L Williams, Sidney B Priesmeyer, Simone E Pitts, Soyinka S Eneng, Stefen D Mcmillan, Stephen C Mahoney, Stephen D Brown, Stephen D Eich, Stephen J Koniers, Steven D Kehoe, Sullan, Susan D Yuscius, Susan M Jackson, Susan P Bruederle, Susan T Hadman, Susan W Ciani, Tamara Brey, Tara L Greene, Tara L King, Tara R Gooen, Ted L Anderson, That Q Dang, Thomas J Arista, Todd M Stankewicz, Torrance J Slayton, Tyler M Peterson, Tyler Peterson, Unnee Ranjan, Vaishali J Patel, Vioela J Caze, Warren J Lopicka, Wayne D Mcgrath, Wayne E Seifert, Wendy G Tan, PhD, William D Sherman, William G Nelson, William J Leonard, William R Weissinger, Xiaoshi N Wang, Yiwei Li, Yongmin Liu, Yuanyuan Li, Yumi J Hiramine, Yvonne E Lozano, Zhang Zhao, PhD

Michele L Glendenning's Documents

Publish Date Document Type Title
January, 2019 FDA 483 Precision Dose Inc. - Form 483, 2019-01-28
February, 2022 FDA 483 COOK BIOTECH INCORPORATED - Form 483, 2022-02-11
January, 2021 FDA 483 DENTAL TECHNOLOGIES, INC. - Form 483, 2021-01-20
November, 2018 FDA 483 Veridian Healthcare - Form 483, 2018-11-28
April, 2015 EIR Fresenius Kabi USA, LLC - EIR, 2015-04-14
December, 2021 FDA 483 Artemis Bio-Solutions - Form 483, 2021-12-01
March, 2020 FDA 483 Surmasis Pharmaceutical, LLC - Form 483, 2020-03-19
August, 2019 FDA 483 Brenntag Great Lakes, LLC - Form 483, 2019-08-02
September, 2022 FDA 483 Hospira Australia Pty Ltd - Form 483, 2022-09-02
April, 2022 EIR Rising Pharma Holdings, Inc. - EIR, 2022-04-08
July, 2019 FDA 483 Maxpax, LLC - Form 483, 2019-07-25
July, 2022 FDA 483 DENTAL TECHNOLOGIES, INC. - Form 483, 2022-07-26
December, 2023 FDA 483 Patheon Biologics LLC - Form 483, 2023-12-08
July, 2023 FDA 483 Medline Industries, LP (f/k/a Medline Industries, Inc.) - Form 483, 2023-07-12
September, 2021 FDA 483 Amsino Healthcare (USA) Inc. - Form 483, 2021-09-20
May, 2020 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2020-05-18
January, 2019 FDA 483 Response Precision Dose Inc. - Form 483R, 2019-02-11
March, 2024 FDA 483 Combe Laboratories, Inc. - Form 483, 2024-03-28
January, 2019 EIR Precision Dose Inc. - EIR, 2019-01-28
November, 2018 EIR Veridian Healthcare - EIR, 2019-01-11
June, 2021 FDA 483 Response Hydrox Laboratories - Form 483R, 2021-07-30
September, 2019 FDA 483 Glenmark Pharmaceuticals Limited - Form 483, 2019-09-27
May, 2018 FDA 483 Response Rising Pharma Holdings, Inc. - Form 483R, 2018-06-07
January, 2015 EIR Elorac Inc. - EIR, 2015-01-20
June, 2021 FDA 483 Hydrox Laboratories - Form 483, 2021-06-24
February, 2017 EIR FIRST PRIORITY INCORPORATED - EIR, 2017-02-01
February, 2024 FDA 483 Accugen Laboratories, Inc. - Form 483, 2024-02-13
May, 2020 FDA 483 Response Fresenius Kabi USA, LLC - Form 483R, 2020-06-05
May, 2016 EIR Xttrium Laboratories, Inc. - EIR, 2016-05-25
June, 2021 EIR Hydrox Laboratories - EIR, 2021-06-24
October, 2019 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2019-10-31
October, 2023 FDA 483 Novartis Manufacturing LLC - Form 483, 2023-10-27
April, 2023 FDA 483 Chemrite Copac, Inc. - Form 483, 2023-04-11
April, 2022 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2022-04-08
January, 2018 EIR Fisher Clinical Services Inc. - EIR, 2018-01-10
May, 2018 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2018-05-16
April, 2018 FDA 483 Pharmedium Services, LLC - Form 483, 2018-04-11
June, 2024 FDA 483 AbbVie Inc. - Form 483, 2024-06-18

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more